Summary:
- The article evaluates the clinical application of Preimplantation Genetic Testing for Aneuploidy (PGT-A) in the context of IVF, emphasizing the need for rigorous scientific scrutiny regarding its efficacy in improving live birth rates.
- It highlights the ethical and biological complexities of PGT-A, specifically the issue of embryo mosaicism, and cautions against the widespread adoption of the technology before clinical evidence definitively proves its universal benefit.